Case Reports in Infectious Diseases
Volume 2016 (2016), Article ID 3720549, 4 pages
http://dx.doi.org/10.1155/2016/3720549

Case Report

Detection of the Dimorphic Phases of Mucor circinelloides in Blood Cultures from an Immunosuppressed Female

Miguel A. Arroyo,1,2 Bryan H. Schmitt,¹ Thomas E. Davis,¹ and Ryan F. Relich¹

¹Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA
²U.S. Army Medical Department Center and School, Fort Sam Houston, TX 78234, USA

Received 1 July 2016; Accepted 15 September 2016

Academic Editor: Paul Horrocks

Copyright © 2016 Miguel A. Arroyo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Mucormycosis fungemia is rarely documented since blood cultures are nearly always negative. We describe a case of Mucor circinelloides fungemia in a patient with a history of a sinus infection, sarcoidosis, and IgG deficiency. The identity of the isolate was supported by its microscopic morphology and its ability to convert into yeast forms under anaerobic conditions. The early detection, initiation of liposomal amphotericin B treatment, and reversal of underlying predisposing risk factors resulted in a good outcome.

1. Introduction

Mucormycoses are infectious diseases caused by filamentous fungi classified among the order Mucorales [1]. Infection occurs when a susceptible (e.g., immunocompromised) human is exposed to spores through inhalation, ingestion, or traumatic implantation. The resulting disease processes are characterized by an often rapid clinical progression and a high mortality rate [1, 2]. Mucorales rarely cause infection in immunocompetent persons but can cause fatal infection in immunocompromised patients. Risk factors include hematologic malignancies, bone marrow or solid organ transplantation, neutropenia, diabetes mellitus, corticosteroids, iron chelation therapy, broad spectrum antibiotics, antifungal prophylaxis, prolonged voriconazole use, cutaneous breakdown (from trauma, surgical wounds, needle-sticks, or burns), hyperalimentation, and severe malnutrition [1, 2]. Features of these organisms that contribute to their virulence include their rapid growth rate and their ability to invade blood vessels [1–3]. The latter characteristic permits their spread throughout the body, enabling access to numerous tissues and organs that may ultimately become infected [2]. However, documented mucormycosis fungemia is very rare, and blood cultures are usually negative. Demonstration of invasive disease by these organisms generally requires the identification of fungal elements directly in clinical specimens via histopathological examination or growth of these organisms from more than one specimen obtained from a normally sterile site [3].

Several Mucor spp., but not all, are known to be dimorphic. This distinct group of zygomycetes exhibits hyphal growth in aerobic conditions and multibudded yeast growth under anaerobic or high-CO₂ conditions [4]. M. circinelloides is one of these species, along with M. racemosus, M. rouxii, M. genevensis, M. bacilliformis, M. subtilissimus, and M. amphibiorum. M. circinelloides infections are well documented in the literature and have been associated with cutaneous, rhinocerebral, and pulmonary infections [5–9]. To our knowledge, only two cases of fungemia caused by this organism have been reported [10, 11]. In this report we describe a case of M. circinelloides fungemia in a female with a prior history of chronic sinus infection, sarcoidosis, and IgG deficiency.

2. Case Report

A 38-year-old female presented to the Emergency Department of a hospital in rural Indiana with shortness of breath and cough, sinus congestion, fevers as high as 39.4°C, nasal drainage, sore throat, and yellow-green sputum production. The patient’s medical history included sarcoidosis, IgG deficiency, and a sinus infection for which she completed treatment with cefdinir 1 week before admission. The patient stated improvement while on antibiotics but symptoms worsened after therapy completion. Upon physical examination, the patient had a temperature of 37.5°C and exhibited moderate respiratory distress with no wheezing, rales, or rhonchi. She was alert, awake, and oriented with no ear, nose, throat, cardiovascular, abdominal, back, extremities, skin, neurological, or psychiatric abnormalities. An X-ray of her chest was unremarkable. Peripheral blood specimens obtained at the time of initial presentation demonstrated leukocytosis, hyperglycemia and low potassium, CO₂, total protein, and magnesium (Table 1). The aerobic blood culture bottles (BD BACTEC™ Plus Aerobic/F) from two sets of blood cultures collected at the time of admission turned positive within 24 hours of incubation in a continuous-monitory blood culture system (BACTEC™ 9240, BD Diagnostics, Sparks, MD). Gram stains of the broth revealed pleomorphic yeast forms and wide, pauciseptate, hyphae with right-angle branching (Figure 1(a)). Yeast forms with single, bipolar, and circumferential buds were observed. Several of the yeast cells observed resembled the yeast phase of Paracoccidioides brasiliensis (Figure 1(b)). The Gram stain findings were reported as “fungal elements present” and were immediately phoned to the clinical care team.

Table 1: Clinical laboratory test results from blood specimens obtained at the time of patient presentation to the ED.

Test
Patient result
Reference range

WBC
13.7k/cumm
3.6–5.17k/cumm

Hgb
11.5 GM/dL
12.0–16.0 GM/dL

MCV
79 fL
81–99 fL

MCH
24.9 pg
27–34 pg

MCHC
31.5 GM/dL
32.0–36.0 GM/dL

RDW
15.8%
11.5–14.5%

Absolute neutrophil
8.2k/cumm
1.7–7.6k/cumm

Absolute lymphocyte
4.0k/cumm
1.0–3.2k/cumm

Absolute eosinophil
0.4k/cumm
0.0–0.3k/cumm

Potassium SerPl QN
2.8 mmol/L
3.5–5.5 mmol/L

Carbon dioxide SerPl QN
21 mmol/L
22–29 mmol/L

Glucose SerPl QN
138 mg/dL
70–99 mg/dL

Magnesium SerPl QN
1.3 mg/dL
1.6–2.9 mg/dL

AST SerPl QN
8 units/L
13–39 units/L

Total protein SerPl QN
6.0 GM/dL
6.4–8.0 GM/dL

(a)

(b)

Figure 1: Gram stain of M. circinelloides dimorphic phases from a positive blood culture. (a) Pauciseptate wide hyphae with right-angle branching (100x magnification). (b) Circumferentially budding yeast resembling the yeast phase of Paracoccidioides brasiliensis (500x magnification).

The following day, mold growth was observed on the aerobic sheep blood agar and chocolate agar plates incubated at 35°C in 5% CO₂ and on potato dextrose and Sabouraud agars incubated at 30°C. Fast-growing, floccose colonies were initially pale gray to yellow, turning brown over time when incubated at 35°C. Microscopic examination of the mold colony by lactophenol cotton blue staining revealed broad, ribbon-like pauciseptate wide hyphae with right-angle branching. Sympodially branched and circinate sporangiophores were observed (Figures 2(a) and 2(b)). Globose sporangia measured within 25–80 μm and contained oval shaped sporangiospores (Figure 2(c)). Columellae were spherical, measuring up to 50 μm in diameter; collarettes were present (Figure 2(d)). Rhizoids and stolons were absent. The identity of the isolate as M. circinelloides was supported by its microscopic morphology, its ability to convert into yeast forms under anaerobic conditions, and its inability to grow at 42°C (Figure 3). Conclusive identification based on molecular and phenotypic methods was above the scope of this study. Following reporting of these findings, the patient was started on liposomal amphotericin B 500 mg IVPB every 24 hours; subsequent blood and sinus cultures were negative. In addition, sinus biopsy results and computerized tomography (CT scan) of the chest and sinuses did not show any clear evidence of fungal involvement. As a consequence, antifungal treatment was discontinued after 6 days and the patient was discharged home without further complications. The patient had no signs of Mucor infection 7 months after discharge.

(a)

(b)

(c)

(d)

Figure 2: Microscopic examination of Mucor circinelloides on PDA by “tape prep” using lactophenol cotton blue stain. (a) Sympodially branched sporangiophores (100x magnification); (b) circinate sporangiophores (200x magnification); (c) deliquescent sporangia (100x magnification); (d) columella with collarette (200x magnification).

Figure 3: Mucor circinelloides yeast forms after cultivation of the isolate on Sabouraud dextrose agar incubated for 48 hrs under anaerobic conditions showing hyphae with single and multipolar buds (unstained, 200x)

3. Discussion

The saprophytic nature of the Mucorales makes the diagnosis of mucormycosis a challenging task when these organisms are isolated from nonsterile sites [1]. Because they are ubiquitous, the presence of these organisms can sometimes be dismissed, as, in many cases, they likely represent contamination of the clinical specimen or culture media. Therefore, it is essential that the physician and laboratory personnel work together to determine the clinical significance of the laboratory results. In most instances, the diagnosis of invasive mucormycosis is usually made when these organisms are identified directly from clinical specimens or isolated in culture from more than one specimen obtained from a normally sterile site. In the case presented, the diagnosis of mucormycosis was made by the isolation of Mucor circinelloides from two blood culture sets that were collected from two different sites. This finding was considered clinically significant since it represented multiple specimens obtained from a normally sterile site.

In this case, the source of infection is unknown, but we hypothesized that is likely related to her sinusitis. The successful treatment and optimal outcome were most likely attributed to the early detection and isolation of the organism from blood cultures, which prompted early implementation of antifungal therapy. In addition, the correction of her hypokalemia, hypomagnesemia, and hyperglycemia contributed to her recovery, as reversal of underlying physiological dyshomeostatic conditions has been reported to correlate with good patient outcomes [12]. Surgical debridement was not necessary since follow-up tests did not reveal foci of fungal infection. Based on the patient outcome, we can also hypothesize that this case might have represented a transient fungemia or that the causative organism is of low virulence [13].

To our knowledge, only two cases of fungemia associated with M. circinelloides have been previously described. The first reported cases occurred in a 48-year-old male with a history of short-gut syndrome secondary to multiple abdominal surgeries [10]. This patient had a central venous catheter (CVC) that was required for chronic total parenteral nutrition. Blood cultures obtained from the CVC on consecutive days grew both Candida albicans and M. circinelloides. Treatment with liposomal amphotericin B was started, and the CVC was removed. Similar to our case, the authors stated that early diagnosis of mucormycosis coupled with rapid therapeutic intervention led to a successful outcome. The second reported case was that of an 83-year-old diabetic woman who developed an acute left frontoparietal infarct while hospitalized in a neurological intensive care unit [11]. The initial isolation of a mold from a blood culture was considered to be a contaminant, but during the following days, the patient developed an erythematous and edematous lesion on her right hand. A skin biopsy culture grew a mold identical to that in the blood culture; both isolates were later identified as M. circinelloides by molecular methods. Despite treatment, the patient’s clinical condition worsened and she later died.

4. Conclusion

This case represents the third documented case of fungemia cause by M. circinelloides. The most likely underlying factors were probably related to her chronic sinus infection, IgG deficiency, and chronic steroid use. The detection of this mold and reversal of the predisposing underlying conditions were vital in the successful treatment.

Disclosure

The views expressed are those of the authors and should not be construed to represent the positions of the U.S. Army or the Department of Defense.

Competing Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.

References

J. A. Ribes, C. L. Vanover-Sams, and D. J. Baker, “Zygomycetes in human disease,” Clinical Microbiology Reviews, vol. 13, no. 2, pp. 236–301, 2000.

G. Petrikkos, A. Skiada, O. Lortholary, E. Roilides, T. J. Walsh, and D. P. Kontoyiannis, “Epidemiology and clinical manifestations of mucormycosis,” Clinical Infectious Diseases, vol. 54, supplement 1, pp. S23–S34, 2012.

I. Weitzman, “Saprophytic molds as agents of cutaneous and subcutaneous infection in the immunocompromised host,” Archives of Dermatology, vol. 122, no. 10, pp. 1161–1168, 1986.

M. Orlowski, “Mucor dimorphism,” Microbiological Reviews, vol. 55, no. 2, pp. 234–258, 1991.

S. P. Lazar, J. M. Lukaszewicz, K. A. Persad, and J. F. Reinhardt, “Rhinocerebral Mucor circinelloides infection in immunocompromised patient following yogurt ingestion,” Delaware Medical Journal, vol. 86, no. 8, pp. 245–248, 2014.

Z. U. Khan, S. Ahmad, A. Brazda, and R. Chandy, “Mucor circinelloides as a cause of invasive maxillofacial zygomycosis: an emerging dimorphic pathogen with reduced susceptibility to posaconazole,” Journal of Clinical Microbiology, vol. 47, no. 4, pp. 1244–1248, 2009.

M. Dodémont, M. Hites, B. Bailly et al., “When you can’t see the wood for the trees. Mucor circinelloides: a rare case of primary cutaneous zygomycosis,” Journal de Mycologie Médicale, vol. 25, no. 2, pp. 151–154, 2015.

P. C. Iwen, L. Sigler, R. K. Noel, and A. G. Freifeld, “Mucor circinelloides was identified by molecular methods as a cause of primary cutaneous zygomycosis,” Journal of Clinical Microbiology, vol. 45, no. 2, pp. 636–640, 2007.

M. Shindo, K. Sato, J. Jimbo et al., “Breakthrough pulmonary mucormycosis during voriconazole treatment after reduced-intensity cord blood transplantation for a patient with acute myeloid leukemia,” Rinsho Ketsueki, vol. 48, no. 5, pp. 412–417, 2007.

K. M. Chan-Tack, L. L. Nemoy, and E. N. Perencevich, “Central venous catheter-associated fungemia secondary to mucormycosis,” Scandinavian Journal of Infectious Diseases, vol. 37, no. 11-12, pp. 925–927, 2005.

M. Dizbay, E. Adisen, S. Kustimur et al., “Fungemia and cutaneous zygomycosis due to Mucor circinelloides in an intensive care unit patient: case report and review of literature,” Japanese Journal of Infectious Diseases, vol. 62, no. 2, pp. 146–148, 2009.

B. Spellberg, J. Edwards Jr., and A. Ibrahim, “Novel perspectives on mucormycosis: pathophysiology, presentation, and management,” Clinical Microbiology Reviews, vol. 18, no. 3, pp. 556–569, 2005.

S. C. Lee, A. Li, S. Calo et al., “Calcineurin orchestrates dimorphic transitions, antifungal drug responses and host-pathogen interactions of the pathogenic mucoralean fungus Mucor circinelloides,” Molecular Microbiology, vol. 97, no. 5, pp. 844–865, 2015.